A detailed history of Perritt Capital Management Inc transactions in Novartis Ag stock. As of the latest transaction made, Perritt Capital Management Inc holds 17 shares of NVS stock, worth $2,232. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17
Previous 2,057 99.17%
Holding current value
$2,232
Previous $248,000 99.19%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$101.96 - $121.01 $207,998 - $246,860
-2,040 Reduced 99.17%
17 $2,000
Q2 2025

Aug 12, 2025

BUY
$101.96 - $121.01 $207,998 - $246,860
2,040 Added 12000.0%
2,057 $248,000
Q1 2025

May 13, 2025

BUY
$97.14 - $115.57 $1,651 - $1,964
17 New
17 $1,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Perritt Capital Management Inc Portfolio

Follow Perritt Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perritt Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perritt Capital Management Inc with notifications on news.